DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
ABSTRACT Introduction: Coronavirus outbreak 2019 (COVID-19) has affected all the
corners of the globe and created chaos to human life. In order to put some control on the …
corners of the globe and created chaos to human life. In order to put some control on the …
The mRNA vaccine technology era and the future control of parasitic infections
Despite intensive long-term efforts, with very few exceptions, the development of effective
vaccines against parasitic infections has presented considerable challenges, given the …
vaccines against parasitic infections has presented considerable challenges, given the …
Perceptions, knowledge and attitudes about COVID-19 vaccine hesitancy in older Portuguese adults
Abstract Background Coronavirus 2019 (COVID-19) has become a public-health emergency
of international concern. Most efforts to contain the spread and transmission of the virus rely …
of international concern. Most efforts to contain the spread and transmission of the virus rely …
[HTML][HTML] Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
H Lei, A Alu, J Yang, W Ren, C He, T Lan… - … and Targeted Therapy, 2022 - nature.com
The outbreak of coronavirus disease 2019 (COVID-19) has posed great threats to global
health and economy. Several effective vaccines are available now, but additional booster …
health and economy. Several effective vaccines are available now, but additional booster …
[HTML][HTML] Effectiveness of COVID‑19 vaccines and their challenges
G Marfe, S Perna, AK Shukla - Experimental and …, 2021 - spandidos-publications.com
At the end of 2019, a new disease recognized such as severe acute respiratory syndrome
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
[HTML][HTML] COVID-19 and liver injury: An ongoing challenge
I Papagiouvanni, SC Kotoulas, A Pataka… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …
[HTML][HTML] Nasal nanovaccines for SARS-CoV-2 to address COVID-19
J Huang, Y Ding, J Yao, M Zhang, Y Zhang, Z Xie… - Vaccines, 2022 - mdpi.com
COVID-19 is still prevalent around the globe. Although some SARS-CoV-2 vaccines have
been distributed to the population, the shortcomings of vaccines and the continuous …
been distributed to the population, the shortcomings of vaccines and the continuous …
Development of virus‐like particles‐based vaccines against coronaviruses
Severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle East respiratory
syndrome coronavirus (MERS‐CoV), and the current severe acute respiratory syndrome …
syndrome coronavirus (MERS‐CoV), and the current severe acute respiratory syndrome …
[HTML][HTML] Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis
W Xu, W Ren, T Wu, Q Wang, M Luo, Y Yi, J Li - Vaccines, 2023 - mdpi.com
With the mass vaccination program for COVID-19 mRNA vaccines, there has been sufficient
real-world study (RWS) on the topic to summarize their safety in the total population and in …
real-world study (RWS) on the topic to summarize their safety in the total population and in …
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 …
Background Information on neurological and psychiatric adverse events following
immunization (AEFIs) with COVID-19 vaccines is limited. Research design & methods We …
immunization (AEFIs) with COVID-19 vaccines is limited. Research design & methods We …